"For over 30 years, Shenandoah Oncology has taken care of patients with cancer and blood disorders. Our physicians have over 100 years of combined experience in caring for patients. We are committed to providing comprehensive and compassionate care to our patients. We offer state-of-the-art therapies that allow our patients to get university-level care close to home. We also provide a broad range of supportive services that help our patients throughout each step of their journey."

During the past decade, Shenandoah Oncology PC conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 35 clinical trials were completed, i.e. on average, 67.3% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 30 clinical trials were completed. i.e. 176.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shenandoah Oncology PC" #1 sponsor was "SWOG Cancer Research Network" with 18 trials, followed by "National Cancer Institute (NCI)" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shenandoah Oncology PC" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Shenandoah Oncology PC" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Breast Cancer" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "HER2/Neu Negative" (4 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "Shenandoah Oncology PC" in a lesser frequency.

Most popular intervention types in "Shenandoah Oncology PC" are "Drug" (54 trials), "Other" (31 trials), "Biological" (17 trials), "Procedure" (8 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Laboratory Biomarker Analysis" (14 trials), "Docetaxel" (11 trials), "Questionnaire Administration" (10 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Shenandoah Oncology PC" are 56 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Shenandoah Oncology PC". undefined are not yet recruiting, 12 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Shenandoah Oncology PC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Shenandoah Oncology PC, 2 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".